Search
Zymeworks Inc
ZYMEAdd to Watchlist
27.500USD
-0.065-0.24%
Close 09-23 16:00（ET）
1.97BMarket Cap
LossP/E TTM
Zymeworks Inc (ZYME) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Zymeworks Inc in the past month.
Buy
4 Strong Buy
8 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
41.917USD+52.06%
ZYME Analyst Recommendation Trends
In the current month, ZYME has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ZYME average Analyst price target in the last month is 41.917.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
4
4
4
4
4
4
4
4
8
8
8
10
10
10
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
12
14
14
14
14
14
ZYME Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, ZYME EPS is projected to reach 2.461 in FY2026Q3, following reported EPS of -0.617 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.42
-0.19
-0.49
2.46
0.15
Actual
-0.55
-0.59
-0.62
--
--
Surprise
-31.41%
-208.04%
-26.95%
--
--
FAQs
What is Zymeworks Inc's expected revenue for the next quarter?
Zymeworks Inc's expected revenue is 234.60M.
What is Zymeworks Inc's price target?
Analysts forecast that Zymeworks Inc's price target is USD 41.92, with the highest forecast at USD 60.00 and the lowest forecast at USD 32.00.
How have Zymeworks IncZYME's recent earnings per share performed?
The market expectation was USD -0.62, while Zymeworks IncZYME's earnings per share (EPS) for the previous quarter was USD -0.59. EPS for the next quarter is expected at USD 2.46.
What is the analyst rating for Zymeworks Inc?
Based on the ratings of Zymeworks Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.